首页 › 肺癌 › 加利福尼亚州 › Santa Rosa
Santa Rosa CA 肺癌临床试验
11项针对 肺癌的研究正在 Santa Rosa及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Kaiser Permanente-Santa Rosa, Santa Rosa
- Saint Helena Hospital, St. Helena · 距离 14 英里
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
招募中3 期
- Kaiser Permanente-Santa Rosa, Santa Rosa
Distance-Based Exercise to Preserve Function and Prevent Disability
招募中
- Kaiser Permanente-Santa Rosa, Santa Rosa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Providence Medical Foundation - Santa Rosa, Santa Rosa
- Providence Santa Rosa Memorial Hospital, Santa Rosa
- Saint Helena Hospital, St. Helena · 距离 14 英里
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Kaiser Permanente-Santa Rosa, Santa Rosa
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
招募中3 期
- Sutter Pacific Medical Foundation, Santa Rosa
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
招募中1/2 期
- Providence Medical Foundation, Santa Rosa
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Sutter Pacific Medical Foundation, Santa Rosa
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
招募中1/2 期
- St Joseph Heritage Healthcare, Santa Rosa
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Sutter Pacific Medical Foundation, Santa Rosa
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
招募中1/2 期
- Providence Medical Foundation (site 209), Santa Rosa
其他城市的 肺癌试验
- Houston, TX78 项研究
- Boston, MA62 项研究
- New York City, NY60 项研究
- Los Angeles, CA45 项研究
- Arlington, VA41 项研究
- Washington, DC41 项研究
- Chicago, IL41 项研究
- Baltimore, MD40 项研究
- Nashville, TN40 项研究
- St. Louis, MO39 项研究
- Columbus, OH37 项研究
- Philadelphia, PA36 项研究
Santa Rosa的其他研究
- 非小细胞肺癌17 项研究
- 癌症（所有类型）11 项研究
- 乳腺癌11 项研究
- 结直肠癌11 项研究
- 转移性癌症9 项研究
- 前列腺癌9 项研究
- 卵巢癌7 项研究
- 胰腺癌6 项研究
- 子宫内膜癌6 项研究
- 结肠癌5 项研究
- 胃癌5 项研究
- 头颈癌4 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。